Butterfly Network Q2 revenue beats on strong U.S. demand
Reuters2026/07/30 10:41
Overview
U.S. ultrasound device maker's Q2 revenue grew 39% yr/yr, beating analyst expectations
Adjusted loss per share for Q2 beat analyst expectations
Company raised full-year revenue and adjusted EBITDA guidance
Outlook
Butterfly Network raises 2026 revenue guidance to $119 mln-$123 mln, up 22%-26%
Company expects Q3 2026 revenue of $26 mln-$30 mln, about 30% growth at midpoint
Company expects first Home Community Care commercial revenue in Q4 2026
Result Drivers
U.S. REVENUE GROWTH - Company said U.S. revenue rose 57% yr/yr, driven by Embedded partnerships and increased probe sales to health systems, medical schools, and eCommerce customers
GROSS MARGIN EXPANSION - Gross margin rose to 71.4%, mainly due to higher-margin Embedded licensing revenue and reduced software amortization costs
INTERNATIONAL REVENUE DECLINE - International revenue fell 14% yr/yr, largely due to decreased probe sales to international distribution partners, partly offset by commercial expansion into Brazil
Company press release: ID:nBw4skbJJa
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 Revenue |
Beat |
$32.60 mln |
$29.36 mln (5 Analysts) |
Q2 Adjusted Loss Per Share |
Beat |
$0.01 |
$0.06 (4 Analysts) |
Q2 Loss Per Share |
|
$0.05 |
|
Q2 Net Loss |
|
$12.90 mln |
|
Q2 Adjusted EBITDA |
|
-$1.40 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment technology peer group is "buy"
Wall Street's median 12-month price target for Butterfly Network Inc is $6.00, about 15.5% below its July 29 closing price of $7.10
Reuters Recommended Reads
July 29 - GE HealthCare tops quarterly estimates, weighs patient care unit sale
July 29 - Glaukos Q2 sales jump 50%; raises net sales forecast
July 29 - Bausch + Lomb Q2 revenue beats on surgical segment growth; lifts outlook
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES <UCFIW.O> REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES <OST.O> REASON NOT AVAILABLE AT 03:28 AM